• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病中的循环可溶性黏附分子

Circulating soluble adhesion molecules in inflammatory bowel disease.

作者信息

Patel R T, Pall A A, Adu D, Keighley M R

机构信息

Department of Surgery, Queen Elizabeth Hospital, Birmingham, UK.

出版信息

Eur J Gastroenterol Hepatol. 1995 Nov;7(11):1037-41. doi: 10.1097/00042737-199511000-00005.

DOI:10.1097/00042737-199511000-00005
PMID:8680902
Abstract

OBJECTIVE

To determine levels of soluble forms of the cell adhesion molecules (CAM), ICAM-1, E-Selectin and VCAM-1 in relation to prevalence, treatment and disease activity in inflammatory bowel disease.

PATIENTS AND METHODS

Plasma was obtained from patients with ulcerative colitis (n = 49), patients with ulcerative colitis who had undergone restorative proctocolectomy (n = 32, eight of whom had a clinical pouchitis), Crohn's disease patients (n = 34) and 24 healthy controls.

RESULTS

Plasma soluble ICAM-1 levels [medians (ranges in ng/ml)] were significantly higher in patients with active ulcerative colitis [270 (90-510)], pouchitis [415 (310-670)] and active Crohn's disease [305 (200-630)] than in those with inactive ulcerative colitis [225 (140-425), P = 0.031], non-inflamed ileoanal pouch [260 (140-380), P = 0.0004] and inactive Crohn's disease [245 (90-520), P = 0.045], respectively, and controls. The soluble E-Selectin levels were also significantly higher in patients with active ulcerative colitis [55 (40-140)], pouchitis [90 (45-145)], and active Crohn's disease [78 (30-115)] than in those with inactive ulcerative colitis [45 (20-80, P = 0.003], non-inflamed ileoanal pouch [45 (20-90), P = 0.001] and inactive Crohn's disease [48 (25-90, P = 0.020], respectively, and controls.

CONCLUSIONS

The present study suggests that increased levels of soluble ICAM-1 and soluble E-Selectin occur during active inflammatory bowel disease and pouchitis, which may be used as sensitive markers of continuing inflammation.

摘要

目的

测定细胞黏附分子(CAM)的可溶性形式,即细胞间黏附分子-1(ICAM-1)、E-选择素和血管细胞黏附分子-1(VCAM-1)的水平,并探讨其与炎症性肠病的患病率、治疗及疾病活动度之间的关系。

患者与方法

采集溃疡性结肠炎患者(n = 49)、接受结直肠全切除回肠储袋肛管吻合术的溃疡性结肠炎患者(n = 32,其中8例有临床袋炎)、克罗恩病患者(n = 34)以及24名健康对照者的血浆。

结果

活动期溃疡性结肠炎患者[270(90 - 510)]、袋炎患者[415(310 - 670)]和活动期克罗恩病患者[305(200 - 630)]的血浆可溶性ICAM-1水平[中位数(单位:ng/ml)]显著高于非活动期溃疡性结肠炎患者[225(140 - 425),P = 0.031]、无炎症的回肠储袋[260(140 - 380),P = 0.0004]和非活动期克罗恩病患者[245(90 - 520),P = 0.045]以及健康对照者。活动期溃疡性结肠炎患者[55(40 - 140)]、袋炎患者[90(45 - 145)]和活动期克罗恩病患者[78(30 - 115)]的可溶性E-选择素水平也显著高于非活动期溃疡性结肠炎患者[45(20 - 80,P = 0.003]、无炎症的回肠储袋[45(20 - 90),P = 0.001]和非活动期克罗恩病患者[48(25 - 90,P = 0.020]以及健康对照者。

结论

本研究表明,在活动期炎症性肠病和袋炎期间,可溶性ICAM-1和可溶性E-选择素水平升高,这可能用作持续炎症的敏感标志物。

相似文献

1
Circulating soluble adhesion molecules in inflammatory bowel disease.炎症性肠病中的循环可溶性黏附分子
Eur J Gastroenterol Hepatol. 1995 Nov;7(11):1037-41. doi: 10.1097/00042737-199511000-00005.
2
Adhesion molecules in inflammatory bowel disease.炎症性肠病中的黏附分子
Gut. 1995 May;36(5):724-30. doi: 10.1136/gut.36.5.724.
3
Elevated serum concentrations of soluble selectin and immunoglobulin type adhesion molecules in patients with inflammatory bowel disease.炎症性肠病患者血清中可溶性选择素和免疫球蛋白型黏附分子浓度升高。
J Gastroenterol. 1997 Aug;32(4):480-6. doi: 10.1007/BF02934086.
4
Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease.炎症性肠病不同活动组患者中的可溶性选择素、可溶性细胞间黏附分子、可溶性血管细胞黏附分子及血管生成蛋白。
Dig Dis Sci. 2004 Aug;49(7-8):1265-74. doi: 10.1023/b:ddas.0000037822.55717.31.
5
Up-regulation of E-selectin and intercellular adhesion molecule-1 differs between Crohn's disease and ulcerative colitis.克罗恩病和溃疡性结肠炎中E-选择素和细胞间黏附分子-1的上调情况有所不同。
Dig Dis Sci. 1995 Jan;40(1):219-25. doi: 10.1007/BF02063969.
6
Increased mucosal concentrations of soluble intercellular adhesion molecule-1 (sICAM-1), sE-selectin, and interleukin-8 in active ulcerative colitis.活动性溃疡性结肠炎中可溶性细胞间黏附分子-1(sICAM-1)、可溶性E-选择素和白细胞介素-8的黏膜浓度升高。
Dig Dis Sci. 1996 Sep;41(9):1780-5. doi: 10.1007/BF02088745.
7
[Adhesion molecules of immunoglobin super family in children and youth with inflammatory bowel disease].[儿童和青少年炎症性肠病中免疫球蛋白超家族的黏附分子]
Pol Merkur Lekarski. 2009 Feb;26(152):101-4.
8
[Soluble cell adhesion molecules in chronic renal graft rejection].[慢性肾移植排斥反应中的可溶性细胞黏附分子]
Pol Arch Med Wewn. 1998 Nov;100(5):410-8.
9
Soluble E-selectin, ICAM-1 and VCAM-1 levels in systemic and coronary circulation in patients with variant angina.变异型心绞痛患者全身及冠脉循环中可溶性E选择素、细胞间黏附分子-1及血管细胞黏附分子-1水平
Cardiovasc Res. 1997 Oct;36(1):37-44. doi: 10.1016/s0008-6363(97)00143-0.
10
[Value of E-selectin and L-selectin determination in children and youth with inflammatory bowel disease].[E-选择素和L-选择素测定在儿童和青少年炎症性肠病中的价值]
Med Wieku Rozwoj. 2007 Oct-Dec;11(4):413-8.

引用本文的文献

1
Identification of Specific Biomarkers and Pathways in the Treatment Response of Infliximab for Inflammatory Bowel Disease: In-Silico Analysis.英夫利昔单抗治疗炎症性肠病反应中特定生物标志物和通路的鉴定:计算机分析
Life (Basel). 2023 Mar 2;13(3):680. doi: 10.3390/life13030680.
2
In Vitro Entero-Capillary Barrier Exhibits Altered Inflammatory and Exosomal Communication Pattern after Exposure to Silica Nanoparticles.暴露于二氧化硅纳米颗粒后,体外肠毛细血管屏障表现出改变的炎症和外泌体通讯模式。
Int J Mol Sci. 2019 Jul 5;20(13):3301. doi: 10.3390/ijms20133301.
3
Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis.
生物标志物与溃疡性结肠炎患者接受维得利珠单抗治疗的临床和内镜结局相关。
Inflamm Bowel Dis. 2019 Jan 10;25(2):410-420. doi: 10.1093/ibd/izy307.
4
The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease.先天免疫系统和适应性免疫系统作为炎症性肠病生物治疗的靶点。
Int J Mol Sci. 2017 Sep 21;18(10):2020. doi: 10.3390/ijms18102020.
5
The role of the intestinal microvasculature in inflammatory bowel disease: studies with a modified Caco-2 model including endothelial cells resembling the intestinal barrier in vitro.肠道微血管在炎症性肠病中的作用:采用改良的Caco-2模型进行的研究,该模型包括在体外模拟肠道屏障的内皮细胞。
Int J Nanomedicine. 2016 Dec 7;11:6353-6364. doi: 10.2147/IJN.S92608. eCollection 2016.
6
Alicaforsen, an antisense inhibitor of ICAM-1, as treatment for chronic refractory pouchitis after proctocolectomy: A case series.Alicaforsen,一种细胞间黏附分子-1 的反义抑制剂,用于治疗直肠结肠切除术后慢性难治性袋炎:病例系列。
United European Gastroenterol J. 2016 Feb;4(1):97-104. doi: 10.1177/2050640615593681. Epub 2015 Jul 3.
7
Infliximab for the treatment of pouchitis.英夫利昔单抗治疗储袋炎。
World J Clin Cases. 2013 Sep 16;1(6):191-6. doi: 10.12998/wjcc.v1.i6.191.
8
Activated eosinophils in association with enteric nerves in inflammatory bowel disease.炎症性肠病中与肠神经相关的活化嗜酸性粒细胞。
PLoS One. 2013 May 22;8(5):e64216. doi: 10.1371/journal.pone.0064216. Print 2013.
9
Acute and chronic pouchitis--pathogenesis, diagnosis and treatment.急性和慢性袋炎——发病机制、诊断和治疗。
Nat Rev Gastroenterol Hepatol. 2012 Apr 17;9(6):323-33. doi: 10.1038/nrgastro.2012.58.
10
Diagnosis and treatment of pouchitis.袋状结肠炎的诊断与治疗。
Gastroenterol Hepatol (N Y). 2008 May;4(5):355-61.